CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242 - IOS Press
Pharmacological Management of Colon Cancer
Comprehensive profiling of 1015 patients' exomes reveals genomic-clinical associations in colorectal cancer | Nature Communications
Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram
Changes in serum concentration of cancer antigen 125 (CA125) during the... | Download Scientific Diagram
Frontiers | Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
Frontiers | Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy Responses
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection - The Lancet Gastroenterology & Hepatology
Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research
IJMS | Free Full-Text | Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
Tumor Marker:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Diagnostics | Free Full-Text | Ultrasound and Clinical Preoperative Characteristics for Discrimination Between Ovarian Metastatic Colorectal Cancer and Primary Ovarian Cancer: A Case-Control Study
REACTIVITY FOR CA 125 IN ADENOCARCINOMAS | Download Table
CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242 - IOS Press
Colon Cancer Treatment - NCI
CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study. | Semantic Scholar
CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242 - IOS Press
Colorectal cancer statistics, 2023 - Siegel - 2023 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Successful treatment of breast metastasis from primary transverse colon cancer: A case report
Frontiers | Sexual Dimorphism in Colon Cancer
Biomedicines | Free Full-Text | Identifying Novel Actionable Targets in Colon Cancer
DrKnowledge - Tumor Markers | Facebook
CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242 - IOS Press
